Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Agile Therapeutics (AGRX)
NASDAQ:AGRX
Agile Therapeutics (AGRX) Stock Price & Analysis
1,462 Followers
AGRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.65 - $16.04
Previous Close$1.73
Volume95.84K
Average Volume (3M)49.21K
Market Cap
$3.33M
Enterprise ValueN/A
Total Cash (Recent Filing)$2.79M
Total Debt (Recent Filing)$2.19M
Price to Earnings (P/E)>-0.1
Beta1.86
Next Earnings
Nov 01, 2023EPS Estimate
-$1.58Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-39.40
Shares Outstanding1,926,510
10 Day Avg. Volume41,452
30 Day Avg. Volume49,206
Standard Deviation0.32
R-Squared0.04
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)-0.29
Price to Sales (P/S)1.04
Price to Cash Flow (P/CF)-0.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$8.50Price Target Upside382.95% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Agile Therapeutics News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AGRX FAQ
What was Agile Therapeutics’s price range in the past 12 months?
Agile Therapeutics lowest stock price was $1.65 and its highest was $16.04 in the past 12 months.
What is Agile Therapeutics’s market cap?
Currently, no data Available
When is Agile Therapeutics’s upcoming earnings report date?
Agile Therapeutics’s upcoming earnings report date is Nov 01, 2023 which is in 40 days.
How were Agile Therapeutics’s earnings last quarter?
Agile Therapeutics released its earnings results on Aug 09, 2023. The company reported -$3.1 earnings per share for the quarter, beating the consensus estimate of -$4.945 by $1.845.
Is Agile Therapeutics overvalued?
According to Wall Street analysts Agile Therapeutics’s price is currently Undervalued.
Does Agile Therapeutics pay dividends?
Agile Therapeutics does not currently pay dividends.
What is Agile Therapeutics’s EPS estimate?
Agile Therapeutics’s EPS estimate is -$1.58.
How many shares outstanding does Agile Therapeutics have?
Agile Therapeutics has 1,926,510 shares outstanding.
What happened to Agile Therapeutics’s price movement after its last earnings report?
Agile Therapeutics reported an EPS of -$3.1 in its last earnings report, beating expectations of -$4.945. Following the earnings report the stock price went down -11.197%.
Which hedge fund is a major shareholder of Agile Therapeutics?
Among the largest hedge funds holding Agile Therapeutics’s share is Perceptive Advisors LLC. It holds Agile Therapeutics’s shares valued at 620K.
---
Agile Therapeutics Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.50 (382.95% Upside)
$8.50 (382.95% Upside)
Hedge Fund Trend
Increased
By 2.0 Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 9.3%
Last 30 Days ▼ 9.3%
News Sentiment
Very Negative
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-89.85%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-61.71%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Agile Therapeutics
Agile Therapeutics, Inc. is a healthcare company, which engages in the development and commercialization of transdermal patch. Its lead product candidate, Twirla, also known as AG200-15, is an investigational low-dose, non-daily prescription contraceptive. The company was founded by Chien Te Yen on December 22, 1997 and is headquartered in Princeton, NJ.
---
Top 5 ETFs holding AGRX
iShares Core S&P Total U.S. Stock Market ETF
$504.45
Up to five ETFs with an Outperform Smart Score that hold AGRX. The ETFs are listed according to market value of AGRX within the ETF
---